In‐Ho Kim

Statistics

Publications

Citations

729

H-Index

Active since

2017

Affiliations

The Catholic University of Korea Seoul St. Mary's Hospital(Current)

Catholic University of Korea

University of Ulsan

Ulsan College

Korea University Medical Center

In‐Ho Kim is an author at The Catholic University of Korea Seoul St. Mary's Hospital specializing in oncology, medicine, and immuno-oncology biomarkers.

ORCID

Publications per year

2017–2024

Publications

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Yoon‐Koo Kang, Jeong Hwan Yook, Young-Kyu Park et al. · Journal of Clinical Oncology · 2021 · 355 citations · Full text

Medicine, Oncology, Surgery +17

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial

Zev A. Wainberg, Yoon‐Koo Kang, Keun‐Wook Lee et al. · Gastric Cancer · 2024 · 68 citations · Full text

Medicine, Oncology, Pharmacology +16

Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY

Yoon‐Koo Kang, Hyung‐Don Kim, Jeong Hwan Yook et al. · Journal of Clinical Oncology · 2024 · 44 citations

Medicine, Oncology, Gastrointestinal Oncology +1

<i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer

Sunho Park, John D. Karalis, Changjin Hong et al. · Clinical Cancer Research · 2022 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer

Seoree Kim, Kabsoo Shin, Jae Myung Park et al. · Journal of the Korean Gastric Cancer Association · 2020 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 13